1. 2022-LBA-414-ESGO Preliminary clinical outcome of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced epithelial ovarian cancer. (27th October 2022) Authors: Moore, Kathleen; Asch, Adam; Moreno, Victor; Calvo, Emiliano; Butler, Marcus; Zugazagoitia, Jon; Hong, David; Galal, Ahmed; Ostios, Lorena; de Miguel, Maria; Lin, Quan; Annareddy, Thejo; Brophy, Francine; Rosenberg, Marisa; Seiders, Theresa; Naidoo, Revashnee; Bath, Natalie; Saro, Jose; Norry, El... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. (10th December 2020) Authors: Blumenschein, George; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin; Heymach, John; Govindan, Ramaswamy; Bachier, Carlos; Spéville, Bernard Doger de; Frigault, Matthew; Olszanski, Anthony; Lam, Vincent; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer. (9th November 2020) Authors: Blumenschein, George; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin; Heymach, John; Govindan, Ramaswamy; Bachier, Carlos; Spéville, Bernard Doger de; Frigault, Matthew; Olszanski, Anthony; Lam, Vincent; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors. (10th December 2020) Authors: Hong, David; Butler, Marcus; Pachynski, Russell; Sullivan, Ryan; Kebriaei, Partow; Boross-Harmer, Sarah; Frigault, Matthew; Dumbrava, Ecaterina; Sauer, Amy; Brophy, Francine; Navenot, Jean-Marc; Fayngerts, Svetlana; Bai, Jane; Norry, Elliot; Fracasso, Paula Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors. (9th November 2020) Authors: Hong, David; Butler, Marcus; Pachynski, Russell; Sullivan, Ryan; Kebriaei, Partow; Boross-Harmer, Sarah; Frigault, Matthew; Dumbrava, Ecaterina; Sauer, Amy; Brophy, Francine; Navenot, Jean-Marc; Fayngerts, Svetlana; Bai, Jane; Norry, Elliot; Fracasso, Paula Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor. (9th November 2020) Authors: Hong, David; Clarke, Jeffrey; Johanns, Tanner; Kebriaei, Partow; Heymach, John; Galal, Ahmed; Saibil, Samuel; Sacher, Adrian; Brophy, Francine; Betts, Gareth; Bath, Natalie; William, Spinner; Tipping, Alex; Tucci, Jessica; Luke, Raymond; Trivedi, Trupti; Lin, Quan; Navenot, Jean-Marc; Fracasso, P... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor. (9th November 2020) Authors: Hong, David; Clarke, Jeffrey; Johanns, Tanner; Kebriaei, Partow; Heymach, John; Galal, Ahmed; Saibil, Samuel; Sacher, Adrian; Brophy, Francine; Betts, Gareth; Bath, Natalie; William, Spinner; Tipping, Alex; Tucci, Jessica; Luke, Raymond; Trivedi, Trupti; Lin, Quan; Navenot, Jean-Marc; Fracasso, P... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patients. Issue 10 (July 2015) Authors: Powles, Thomas; Bracarda, Sergio; Chen, Mei; Norry, Elliot; Compton, Natalie; Heise, Mark; Hutson, Thomas; Harter, Philipp; Carpenter, Christopher; Pandite, Lini; Kaplowitz, Neil Journal: European journal of cancer Issue: Volume 51:Issue 10(2015:Jul.) Page Start: 1293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Fludarabine and neurotoxicity in engineered T-cell therapy. Issue 3 (June 2018) Authors: Lowe, Kate; Mackall, Crystal; Norry, Elliot; Amado, Rafael; Jakobsen, Bent; Binder, Gwendolyn Journal: Gene therapy Issue: Volume 25:Issue 3(2018) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab. Issue 7 (7th July 2021) Authors: Kim, Sang T.; Tayar, Jean; Fu, Siqing; Ke, Danxia; Norry, Elliot; Sun, Amy; Miller, Juli; Hong, David S. Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗